1. Home
  2. UVV vs ATRC Comparison

UVV vs ATRC Comparison

Compare UVV & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$53.79

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo AtriCure Inc.

ATRC

AtriCure Inc.

HOLD

Current Price

$30.18

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
ATRC
Founded
1886
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
UVV
ATRC
Price
$53.79
$30.18
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$51.17
AVG Volume (30 Days)
298.5K
766.5K
Earning Date
05-28-2026
05-05-2026
Dividend Yield
6.25%
N/A
EPS Growth
N/A
74.74
EPS
1.30
N/A
Revenue
$2,885,078,000.00
$201,630,000.00
Revenue This Year
$0.67
$15.27
Revenue Next Year
$0.10
$12.21
P/E Ratio
$40.90
N/A
Revenue Growth
N/A
15.40
52 Week Low
$49.19
$25.36
52 Week High
$59.38
$43.18

Technical Indicators

Market Signals
Indicator
UVV
ATRC
Relative Strength Index (RSI) 52.38 60.08
Support Level $51.57 $28.41
Resistance Level $54.14 $30.75
Average True Range (ATR) 1.07 1.12
MACD 0.01 0.18
Stochastic Oscillator 72.10 94.87

Price Performance

Historical Comparison
UVV
ATRC

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: